These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7594597)

  • 1. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).
    Spear GT; Lurain NS; Parker CJ; Ghassemi M; Payne GH; Saifuddin M
    J Immunol; 1995 Nov; 155(9):4376-81. PubMed ID: 7594597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.
    Ziller F; Macor P; Bulla R; Sblattero D; Marzari R; Tedesco F
    Eur J Immunol; 2005 Jul; 35(7):2175-83. PubMed ID: 15971270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells.
    Spiller OB; Morgan BP; Tufaro F; Devine DV
    Eur J Immunol; 1996 Jul; 26(7):1532-8. PubMed ID: 8766557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
    Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
    Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
    Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
    Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
    Goslings WR; Blom DJ; de Waard-Siebinga I; van Beelen E; Claas FH; Jager MJ; Gorter A
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1884-91. PubMed ID: 8759358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction.
    Saifuddin M; Hedayati T; Atkinson JP; Holguin MH; Parker CJ; Spear GT
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1907-11. PubMed ID: 9266986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.
    Montefiori DC; Cornell RJ; Zhou JY; Zhou JT; Hirsch VM; Johnson PR
    Virology; 1994 Nov; 205(1):82-92. PubMed ID: 7526538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo.
    Sullivan BL; Knopoff EJ; Saifuddin M; Takefman DM; Saarloos MN; Sha BE; Spear GT
    J Immunol; 1996 Aug; 157(4):1791-8. PubMed ID: 8759769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of GPI-anchored complement regulatory proteins CD55 and CD59 differentiates two subpopulations of human CD56+ CD3- lymphocytes (NK cells).
    Solomon KR; Chan M; Finberg RW
    Cell Immunol; 1995 Oct; 165(2):294-301. PubMed ID: 7553895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complement regulatory proteins CD55 (decay accelerating factor) and CD59 are expressed on the inner acrosomal membrane of human spermatozoa as well as CD46 (membrane cofactor protein).
    Cummerson JA; Flanagan BF; Spiller DG; Johnson PM
    Immunology; 2006 Jul; 118(3):333-42. PubMed ID: 16827894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement regulatory proteins in normal human esophagus and esophageal squamous cell carcinoma.
    Shimo K; Mizuno M; Nasu J; Hiraoka S; Makidono C; Okazaki H; Yamamoto K; Okada H; Fujita T; Shiratori Y
    J Gastroenterol Hepatol; 2004 Jun; 19(6):643-7. PubMed ID: 15151618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1.
    Saifuddin M; Parker CJ; Peeples ME; Gorny MK; Zolla-Pazner S; Ghassemi M; Rooney IA; Atkinson JP; Spear GT
    J Exp Med; 1995 Aug; 182(2):501-9. PubMed ID: 7543140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM secreted by human T lymphoma virus-I-infected and transformed human B cell clones recognize a 66-kilodalton host-encoded protein.
    Ng VL; Rainer C; Oliver MR; Marsh J; Wood P; Reyes GR; McGrath MS
    J Immunol; 1989 Oct; 143(8):2501-7. PubMed ID: 2477445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the interaction between respiratory syncytial virus and lipid-rafts in Hep2 cells during infection.
    Brown G; Jeffree CE; McDonald T; Rixon HW; Aitken JD; Sugrue RJ
    Virology; 2004 Oct; 327(2):175-85. PubMed ID: 15351205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
    Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
    Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glycosylphosphatidylinositol specific phospholipase D gene expression levels on complement mediated killing of leukemic cells in patients with chronic myeloid leukemia.
    Jian-Hua T; Xiao-Jie Z; Yi-Dan W; Wen-Kai L; Wang-Jiao H; Cheng-Hong W; Gui-Yuan L
    Clin Chim Acta; 2005 Sep; 359(1-2):115-24. PubMed ID: 15907827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors.
    Ravindranath NM; Shuler C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):231-9. PubMed ID: 17234541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of different flow cytometry-based immunophenotypic methods for the analysis of CD59 and CD55 expression on major peripheral blood cell subsets.
    Hernández-Campo PM; Martín-Ayuso M; Almeida J; López A; Orfao A
    Cytometry; 2002 Jun; 50(3):191-201. PubMed ID: 12116342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias.
    Ruiz-Argüelles A; Llorente L
    Autoimmun Rev; 2007 Jan; 6(3):155-61. PubMed ID: 17289551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.